tradmap

GUTS Financials FRACTYL HEALTH, INC.

3 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Financial health

  • The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
-$141M -$70M $120000 $0 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
-100571% -50262% 46% 0% 2023 2024 2025
GrossOperatingNet
Free cash flow (CFO − capex)
-$91M -$45M $0 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $41M $82M 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$90M $7M $105M $0 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $0 -$141M -$91M $82M
2024 $93000 -$69M 46.2% -100571.0% -$67M $67M
2023 $120000 -$77M 35.8% -42363.3% -$43M $33M

Valuation over time

How the market has priced GUTS against its own fundamentals since 2024-02 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 6061.7 12123.4 Feb '24 Jun '24 Oct '24 Feb '25 Jun '25 Oct '25 Feb '26 Jun '26
P/S

Frequently asked questions

Is GUTS growing its revenue and profit?

See the revenue and net-income charts above for FRACTYL HEALTH, INC.'s multi-year trend.

How much debt does GUTS have?

As of FY2025, FRACTYL HEALTH, INC. reported — of total debt against $82M of cash.

What is GUTS's profit margin?

In FY2025, gross margin was —, operating margin —, and net margin —.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.